Biodexa Pharmaceuticals Plc (BDRX) has released an update.
Biodexa Pharmaceuticals PLC has entered into an exclusive license and collaboration agreement with Emtora Biosciences to develop, distribute, market, and sell Emtora’s intellectual property in a specified territory. This follows Biodexa’s prior loan of $250,000 to Emtora under a promissory note. The agreement outlines the management of intellectual property rights, adherence to accounting standards, and the definition of various terms critical to the partnership.
For further insights into BDRX stock, check out TipRanks’ Stock Analysis page.
